Abstract:Imidazolium bromide ionic liquids such as 1-alkyl-3-methylimidazolium bromides ([AMIm]Br) and 1-alkyl-2,3-dimethylimidazolium bromides ([AMMIm]Br) are common-use organic salts. However, data on comparative toxicological effects of these ILs are lacking for fish. In this study, a combined experimental and theoretical approach was applied to compare and analyze the effects of these ILs on biochemical biomarkers in liver of Carassius auratus treated with different concentrations (2 and 20mg/L) for 3 and 16d. Changes in the activities of superoxide dismutase, catalase, glutathione peroxidase, and in the levels of reduced glutathione and malondialdehyde were detected, indicating that these ILs exhibit potential biotoxicity. The integrated biomarker response (IBR) index suggested that 1-hexyl-3-methylimidazolium bromide ([HMIm]Br), 1-octyl-3-methylimidazolium bromide ([OMIm]Br), 1-hexyl-2,3-dimethylimidazolium bromide ([HMMIm]Br), and 1-octyl-2,3-dimethylimidazolium bromide ([OMMIm]Br) showed the highest biotoxicity under different concentrations or exposure time, while 1-ethyl-3-methylimidazolium bromide ([EMIm]Br) always showed the least stressful power towards the test organism. Quantum chemical calculations (electronic parameters, frontier molecular orbitals, and Wiberg bond order) were also conducted to interpret the experimental results. Notably, some descriptors were correlated with the toxicity order. In addition, theoretical calculations provided some valuable information on metabolic pathways of these ILs, which may help to get better understanding on their environmental behavior and fate. In general, the toxicological determination and analysis of these ILs were performed with a combined experimental and theoretical method, which may contribute to the future ecotoxicological studies.

Risk-focused investigation on ionic liquids against their applied background in transdermal delivery

Effects of imidazolium ionic liquids on skin barrier lipids – Perspectives for drug delivery

Design Principles and Applications of Ionic Liquids for Transdermal Drug Delivery

Ionic liquids as the effective technology for enhancing transdermal drug delivery: Design principles, roles, mechanisms, and future challenges

Ionic liquid transdermal delivery system: Progress, prospects, and challenges

An insight into pharmaceutical challenges with ionic liquids: where do we stand in transdermal delivery?

Recent Developments in Ionic Liquid-Assisted Topical and Transdermal Drug Delivery

Ionic Liquids for Enhanced Drug Delivery: Recent Progress and Prevailing Challenges

Applications and Mechanisms of Ionic Liquids in Whole-Cell Biotransformation.

Ionic liquid-based transdermal delivery of propranolol: a patent evaluation of US2018/0169033A1.

Ionic liquids and their potential use in development and improvement of drug delivery systems: evidence of their tendency to promote drug accumulation in the brain

Comparative antioxidant status in freshwater fish Carassius auratus exposed to eight imidazolium bromide ionic liquids: a combined experimental and theoretical study

Study of Green Solvents 1-Butyl-3-methy-limidazolium Ionic Liquids' Structure and Properties

Improving Dermal Delivery of Hydrophilic Macromolecules by Biocompatible Ionic Liquid Based on Choline and Malic Acid.

Enhancing the Solubility and Transdermal Delivery of Drugs Using Ionic Liquid‐In‐Oil Microemulsions

Enhanced Transdermal Delivery of Insulin by Choline-Based Ionic Liquids

Biocompatible ionic liquid enhances transdermal antigen peptide delivery and preventive vaccination effect.

The Distinct Effects of Two Imidazolium-Based Ionic Liquids, [c4mim][oac] and [c6mim][oac], on the Phase Behaviours of DPPC.

Metabolomic analysis of Scenedesmus obliquus reveals new insights into the phytotoxicity of imidazolium nitrate ionic liquids

Ionic Liquids: Green and Tailor-Made Solvents in Drug Delivery

Emerging Impacts of Ionic Liquids on Eco-Environmental Safety and Human Health